Rubin Steven D 4

What Happened
Steven D. Rubin, a director of Entera Bio Ltd. (ENTX), reported a purchase of 5,000 shares on Feb 12, 2026. The shares were acquired at $1.49 per share for a total transaction value of $7,450. The filing reports the transaction as a purchase (code P / "open market or private purchase").

Key Details

• Transaction date and price: Feb 12, 2026 — 5,000 shares @ $1.49 each.
• Total value: $7,450.
• Filing date: Form 4 filed Feb 17, 2026 (appears to be filed five days after the transaction).
• Shares owned after the transaction: not specified in the information provided.
• Notable footnotes: none reported in the supplied summary (no 10b5-1 plan, tax withholding, or exercise noted).
• Transaction code: P (purchase).

Context
This was a straight equity purchase rather than an option exercise or gift. Purchases by insiders can be interpreted by some investors as a positive signal, but the dollar amount here is modest ($7.45k) and may not be material. The Form 4’s Feb 17 filing date is later than the typical two-business-day filing window for insider trades, which may indicate a delayed filing.